Novome Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Novome Biotechnologies's estimated annual revenue is currently $1.7M per year.
- Novome Biotechnologies's estimated revenue per employee is $77,500
- Novome Biotechnologies's total funding is $38M.
Employee Data
- Novome Biotechnologies has 22 Employees.
- Novome Biotechnologies grew their employee count by -64% last year.
Novome Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 150% | N/A | N/A |
#5 | $1.4M | 9 | 0% | N/A | N/A |
#6 | $11.5M | 74 | -12% | N/A | N/A |
#7 | $0.4M | 275 | 10% | $236.7M | N/A |
#8 | $4M | 51 | -74% | $160M | N/A |
#9 | $2.5M | 16 | 33% | N/A | N/A |
#10 | $3.3M | 21 | -12% | N/A | N/A |
What Is Novome Biotechnologies?
Novome Biotechnologies is engineering bacteria from the human gut to treat diseases. Based on pioneering technology developed at Stanford University, we bring together experts in the fields of synthetic biology and the microbiome to build novel cell-based therapies.
keywords:N/A$38M
Total Funding
22
Number of Employees
$1.7M
Revenue (est)
-64%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Novome Biotechnologies News
2020-01-09 - Novome Biotechnologies Secures $33M in Series A Financing
Novome Biotechnologies, Inc., a South San Francisco, Calif.-based biotechnology company engineering living medicines for chronic diseases, secured $33m in Series A financing. The round was led by DCVC Bio with participation from seed investor 5AM Ventures, Alta Partners, Alexandria Venture Inve ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 22 | -80% | $187M |
#2 | $3.4M | 22 | 22% | N/A |
#3 | $3.6M | 23 | -21% | N/A |
#4 | $3.7M | 24 | 0% | N/A |
#5 | $4.1M | 24 | -23% | N/A |